1. Home
  2. Clinical Topics
  3. FDA warns against counterfeit Adderall
Clinical TopicsDrugs and DevicesNewsPatient SafetyWeb ExclusivesWorkplace Management

FDA warns against counterfeit Adderall

Share

On May 29, the U.S. Food and Drug Administration (FDA) warned consumers and healthcare professionals about a counterfeit version of Teva Pharmaceutical Industries’ Adderall 30 milligram tablets that is being purchased on the Internet. The FDA found that the counterfeit contains the wrong active ingredients. Read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts